T. Demenishina

13 September 2023

Beforpharma attended EANM’23 Annual Congress in Vienna

Beforpharma Team attended 36th Annual Congress of the European Association of Nuclear Medicine (EANM’23) held from 9th to 13th September in Vienna. The Congress took place […]
24 August 2023

Opportunity for Senior Scientist – Uniba and Beforpharma

ONE 2-5 years SENIOR SCIENTIST OPPORTUNITY in Biotechnology and Bio-Radiopharmaceuticals for Cancer Therapy in collaboration with Department of Bioscience, Biotechnology and Environment, University of Bari Aldo […]
1 June 2023

Wired Digital Day. Radiopharma Tech

Roberto La Forgia, CEO of Beforpharma srl, delivered a thought-provoking presentation ‘Radiopharmaceutical Tech: transversal ecosystem to fight cancer’ at Wired Digital Day 2023 held in Lecce […]
29 May 2023

Beforpharma attends AIMN 2023 Congress in Catania

Beforpharma Team attended AIMN 2023 Congress  The National Congress of Italian Association of Nuclear Medicine and Molecular Imaging (AIMN) is held annually in different cities of […]
20 April 2023

Beforpharma received a patent for Ga-68 PSMA cold kit technology

In February 2023, Beforpharma and University of Bari received national patent (with international extension) for a technology of cold kit based on PSMA ligands for the […]
6 September 2022

BeForPharma is strengthening Employer Brand with Adecco Italia

In August 2022 BeForPharma Srl signed an agreement with Adecco Italia Spa aimed at strengthening Employer Brand and attracting new talented professionals in the field of […]